Eduard Esteller1, Adriana Agüero2, María Martel2, Montserrat López2, Miquel Quer2, Xavier León3. 1. Otorhinolaryngology Department, Hospital General de Catalunya, San Cugat del Vallès, Barcelona, Spain. 2. Otorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona, Barcelona, Spain. 3. Otorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona, Barcelona, Spain; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain. Electronic address: xleon@santpau.cat.
Abstract
OBJECTIVE: Stomal recurrence following a temporary tracheostomy in the management of the head and neck squamous cell carcinoma (HNSCC) without laryngectomy is a rare finding. We studied the incidence and prognostic significance of stomal recurrence in patients who had a temporary tracheostomy. METHODS: Data were obtained retrospectively from a database on all patients with a HNSCC tumour diagnosed and treated at our hospital between 1985 and 2012. RESULTS: Of 491 patients who underwent temporary tracheostomy, six presented tumour recurrence in the stomal scar. The risk of stomal recurrence after a temporary tracheostomy was therefore 1.2% (6/491). Only one of the three patients who received salvage treatment achieved disease control. CONCLUSION: Tumour recurrence in the stomal scar after a transitory tracheostomy in patients with head and neck carcinoma has an incidence of around 1% and very poor prognosis.
OBJECTIVE: Stomal recurrence following a temporary tracheostomy in the management of the head and neck squamous cell carcinoma (HNSCC) without laryngectomy is a rare finding. We studied the incidence and prognostic significance of stomal recurrence in patients who had a temporary tracheostomy. METHODS: Data were obtained retrospectively from a database on all patients with a HNSCC tumour diagnosed and treated at our hospital between 1985 and 2012. RESULTS: Of 491 patients who underwent temporary tracheostomy, six presented tumour recurrence in the stomal scar. The risk of stomal recurrence after a temporary tracheostomy was therefore 1.2% (6/491). Only one of the three patients who received salvage treatment achieved disease control. CONCLUSION:Tumour recurrence in the stomal scar after a transitory tracheostomy in patients with head and neck carcinoma has an incidence of around 1% and very poor prognosis.
Authors: Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee Journal: Clin Exp Otorhinolaryngol Date: 2017-01-03 Impact factor: 3.372